Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vericel Corp (VCEL)  
$48.10 0.55 (1.13%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 52,373,000
Market Cap: 2.52(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $30.85 - $52.9
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  474
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 134,738 259,234 263,234 303,833
Total Sell Value $6,189,261 $10,761,080 $10,907,920 $12,010,179
Total People Sold 5 7 7 7
Total Sell Transactions 12 29 31 34
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 394
  Page 2 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Flynn Sean C. SVP, General Counsel   •       •      –    2024-02-20 4 D $49.50 $160,875 D/D (3,250) 8,282     -
   Flynn Sean C. SVP, General Counsel   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 7,075 9,059     -
   Halpin Michael Chief Operating Officer   •       •      –    2024-02-20 4 D $49.50 $283,685 D/D (5,731) 8,823     -
   Halpin Michael Chief Operating Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 11,887 10,155     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       •      –    2024-02-20 4 D $49.50 $112,266 D/D (2,268) 19,288     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 7,380 20,097     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2024-02-20 4 D $49.50 $153,747 D/D (3,106) 57,953     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 7,075 58,695     -
   Colangelo Dominick President and CEO   •       •      –    2024-02-20 4 D $49.50 $892,238 D/D (18,025) 194,870     -
   Colangelo Dominick President and CEO   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 38,887 199,013     -
   Siegal Jonathan Principal Accounting Officer   •       •      –    2024-02-20 4 D $49.50 $63,657 D/D (1,286) 3,034     -
   Siegal Jonathan Principal Accounting Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 2,920 3,203     -
   Colangelo Dominick President and CEO   •       •      –    2024-02-15 4 AS $48.85 $854,875 D/D (17,500) 174,008 -3%     
   Colangelo Dominick President and CEO   •       •      –    2024-02-15 4 OE $3.02 $52,850 D/D 17,500 191,508     -
   Colangelo Dominick President and CEO   •       •      –    2024-02-14 4 AS $46.99 $822,325 D/D (17,500) 174,008 1%     
   Colangelo Dominick President and CEO   •       •      –    2024-02-14 4 OE $3.02 $52,850 D/D 17,500 191,508     -
   Colangelo Dominick President and CEO   •       •      –    2024-02-12 4 D $47.42 $164,879 D/D (3,477) 174,008     -
   Colangelo Dominick President and CEO   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 7,500 177,485     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2024-02-12 4 D $47.42 $36,751 D/D (775) 53,984     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 1,625 54,759     -
   Halpin Michael Chief Operating Officer   •       •      –    2024-02-12 4 D $47.42 $84,502 D/D (1,782) 2,667     -
   Halpin Michael Chief Operating Officer   •       •      –    2024-02-12 4 OE $0.00 $0 D/D 3,500 4,449     -
   Zerbe Robert L Md   •       •      –    2024-01-29 4 AS $44.22 $101,706 D/D (2,300) 23,395 8%     
   Zerbe Robert L Md   •       •      –    2024-01-25 4 AS $44.02 $8,804 D/D (200) 25,695 13%     
   Zerbe Robert L Md   •       •      –    2024-01-22 4 AS $41.39 $334,775 D/D (8,000) 25,895 14%     
  394 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us